Effect of tripterygium glycosides on serum ion and β2-GPI/ox-LDL in patients with IgA nephropathy
- VernacularTitle:雷公藤多苷对IgAN患者血清离子及β2-GPI／ox-LDL影响
- Author:
Jianyun PENG
;
Zhen SU
- Publication Type:Journal Article
- Keywords:
tripterygium glycosides;
IgA nephropathy;
ion;
beta 2-GPI/ox-LDL
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;(11):139-141
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyse effect of tripterygium glycosides on serum ion and β2-GPI/ox-LDL in patients with IgA nephropathy. Methods 54 patients who were diagnosed with primary IgA nephropathy in our hospital were collected.All patients were randomly divided into experimental group and control group, 27 cases in each group.Control group was given conventional Benazepri1 Hydrochloride Tablets 10 mg, 1 times per day orally;given Dipyridamole Tablets 50 mg, 3 times per day orally, patients in experimental group were given tripterygium glycosides 20 mg on the basis of control group treatment orally,3 times per day.All the patients were treated for 6 month.After the treatment, the serum levels of Ca,P,β2-GPI/ox-LDL and renal function related index were detected in all patients.Results Compared with control group post-treatment, the serum level of Ca was higher(P<0.05); and the serum level of P was lower in experimental group(P<0.05); the serum level of β2-GPI/ox-LDL was lower in experimental group(P<0.05);the serum levels of Scr and BUN were lower in experimental group(P<0.05).Conclusion The tripterygium glycosides can significantly reduce the serum levels of P,β2-GPI/ox-LDL,Scr and BUN,and increase serum Ca level in patients with IgA nephropathy, improve renal function.
